Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOPHISTICATE: subcutaneous adalimumab for hidradenitis suppurativa
2006-005297-48Phase 2Completed
- Sponsor
- University of Copenhagen
- Start
- Nov 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of adalimumab in hidradenitis suppurativa (HS), sponsored by University of Copenhagen. Primary endpoint: Clinical efficacy at week 12. Started Nov 2006; status: completed.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2006-005297-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005297-48.